Mostrar el registro sencillo del ítem
GENYOi005-A: An induced pluripotent stem cells (iPSCs) line generated from a patient with Familial Platelet Disorder with associated Myeloid Malignancy (FPDMM) carrying a p.Thr196Ala variant
dc.contributor.author | Lamolda, Mar | |
dc.contributor.author | Montes, Rosa | |
dc.contributor.author | Simón, Iris | |
dc.contributor.author | Perales Romero, Sonia | |
dc.contributor.author | Martínez Navajas, Gonzalo | |
dc.contributor.author | López Onieva, Lourdes | |
dc.contributor.author | Ríos Pelegrina, Rosa María | |
dc.contributor.author | García Del Moral Garrido, Raimundo | |
dc.contributor.author | Griñán Lisón, Carmen | |
dc.contributor.author | Marchal Corrales, Juan Antonio | |
dc.contributor.author | Lozano, María L. | |
dc.contributor.author | Ramos Mejía, Verónica | |
dc.contributor.author | Rivera, José | |
dc.contributor.author | Bastida, José M. | |
dc.contributor.author | Real, Pedro J. | |
dc.date.accessioned | 2020-01-24T08:57:51Z | |
dc.date.available | 2020-01-24T08:57:51Z | |
dc.date.issued | 2019-10-15 | |
dc.identifier.citation | Lamolda, M., Montes, R., Simón, I., Perales, S., Martínez-Navajas, G., Lopez-Onieva, L., ... & Lozano, M. L. (2019). GENYOi005-A: An induced pluripotent stem cells (iPSCs) line generated from a patient with Familial Platelet Disorder with associated Myeloid Malignancy (FPDMM) carrying a p. Thr196Ala variant. Stem cell research, 41, 101603. | es_ES |
dc.identifier.uri | http://hdl.handle.net/10481/59102 | |
dc.description.abstract | Familial Platelet Disorder with associated Myeloid Malignancy (FPDMM) is a rare platelet disorder caused by mutations in RUNX1. We generated an iPSC line (GENYOi005-A) from a FPDMM patient with a non-previously reported variant p.Thr196Ala. Non-integrative Sendai viruses expressing the Yamanaka reprogramming factors were used to reprogram peripheral blood mononuclear cells from this FPDMM patient. Characterization of GENYOi005-A included genetic analysis of RUNX1 locus, Short Tandem Repeats profiling, alkaline phosphatase enzymatic activity, expression of pluripotency-associated factors and differentiation studies in vitro and in vivo. This iPSC line will provide a powerful tool to study developmental alterations of FPDMM patients | es_ES |
dc.description.sponsorship | This work was supported by the Ramon y Cajal (RYC-2015-18382) to PJR founded by the Ministry of Economy and Competitiveness; the Instituto de Salud Carlos III-FEDER (CP12/03175 and CPII17/00032) to V.R-M., (PI17/01311) to M.L.L and J.R., (PI17/01966; Fundación Mutua Madrileña AP172142019; Premio Lopez Borrasca SETH 2019; GRS2061/A/19) to J.M.B. and (CPII15/00018 and PI16/01340) to PJR; by the Chair "Doctors Galera-Requena in cancer stem cell research" (CMC-CTS963) to J.A.M. and C.G-L. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Elsevier BV | es_ES |
dc.rights | Atribución-NoComercial-SinDerivadas 3.0 España | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/es/ | * |
dc.title | GENYOi005-A: An induced pluripotent stem cells (iPSCs) line generated from a patient with Familial Platelet Disorder with associated Myeloid Malignancy (FPDMM) carrying a p.Thr196Ala variant | es_ES |
dc.type | journal article | es_ES |
dc.rights.accessRights | open access | es_ES |
dc.identifier.doi | 10.1016/j.scr.2019.101603 |